These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7762116)

  • 1. [Hyperfibrinogenemia and cardiovascular risk--epiphenomenon or causal relationship?].
    Koenig W
    Versicherungsmedizin; 1995 Apr; 47(2):52-5. PubMed ID: 7762116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An update on the role of fibrinogen in the atherothrombotic process].
    Gatto E; Gatto R; Maragliano E
    Minerva Cardioangiol; 1994; 42(1-2):1-9. PubMed ID: 8022539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention].
    Baller D; Gleichmann U; Miche E; Mannebach H; Seggewiss H
    Versicherungsmedizin; 1995 Apr; 47(2):55-60. PubMed ID: 7762117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Schulte H; von Eckardstein A; Heinrich J; Assmann G; Koehler E
    Coron Artery Dis; 2001 May; 12(3):157-65. PubMed ID: 11352071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen: its emerging role as a cardiovascular risk factor.
    Ernst E
    Angiology; 1994 Feb; 45(2):87-93. PubMed ID: 8129195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    Ernst E
    Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement components and fibrinogen: correlations and association with previous myocardial infarction.
    Muscari A; Bozzoli C; Massarelli G; Puddu GM; Palareti G; Legnani C; D'Atena T; Mazzuca A; Miniero R; Toscano V
    Cardiology; 1995; 86(3):232-7. PubMed ID: 7614496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen as a risk factor for stroke and myocardial infarction.
    Wilhelmsen L; Svärdsudd K; Korsan-Bengtsen K; Larsson B; Welin L; Tibblin G
    N Engl J Med; 1984 Aug; 311(8):501-5. PubMed ID: 6749207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
    Howard SC; Algra A; Rothwell PM;
    Cerebrovasc Dis; 2008; 25(1-2):136-43. PubMed ID: 18073467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods for decreasing risk in peripheral arterial occlusive disease patients. Interview by Dr. rer. nat. Till Uwe Keil].
    Spengel FA
    Fortschr Med; 1998 Oct; 116(28):29-30. PubMed ID: 9844263
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring plasma fibrinogen to predict stroke and myocardial infarction.
    Di Minno G; Mancini M
    Arteriosclerosis; 1990; 10(1):1-7. PubMed ID: 2404490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.
    Maresca G; Di Blasio A; Marchioli R; Di Minno G
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1368-77. PubMed ID: 10364066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
    Bosevski M; Kostoska S; Tosev S; Borozanov V
    Angiol Sosud Khir; 2006; 12(2):9-15. PubMed ID: 17053757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen degradation products.
    Sack ES; Buraschi J
    N Engl J Med; 1971 Jun; 284(25):1441. PubMed ID: 5578330
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When will fibrinogen screening become available?].
    Ernst E
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.